|
FAM55C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.611430E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.98620000005467E-06 |
| Normal-vs-Stage2 |
1.534820E-01 |
| Normal-vs-Stage3 |
5.973200E-01 |
| Normal-vs-Stage4 |
6.442200E-01 |
| Stage1-vs-Stage2 |
3.152000E-01 |
| Stage1-vs-Stage3 |
1.517000E-01 |
| Stage1-vs-Stage4 |
4.823200E-01 |
| Stage2-vs-Stage3 |
5.865400E-01 |
| Stage2-vs-Stage4 |
7.728600E-01 |
| Stage3-vs-Stage4 |
8.921800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.72930000000138E-05 |
| Normal-vs-AfricanAmerican |
8.820200E-03 |
| Normal-vs-Asian |
6.727000E-01 |
| Caucasian-vs-AfricanAmerican |
6.453000E-01 |
| Caucasian-vs-Asian |
5.708600E-01 |
| AfricanAmerican-vs-Asian |
7.042800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.12069999958342E-07 |
| Normal-vs-Female |
9.984200E-01 |
| Male-vs-Female |
2.387700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.201820E-01 |
| Normal-vs-Extreme_Weight |
1.72099999999897E-05 |
| Normal-vs-Obese |
5.437800E-03 |
| Normal-vs-Extreme_Obese |
5.284400E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.529900E-02 |
| Normal_Weight-vs-Obese |
4.720600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.203800E-01 |
| Extreme_Weight-vs-Obese |
3.389000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.782000E-01 |
| Obese-vs-Extreme_Obese |
6.657800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.345000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.663400E-03 |
| Normal-vs-Age(61-80Yrs) |
7.52850000000915E-05 |
| Normal-vs-Age(81-100Yrs) |
2.179600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.200400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.632600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.088620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.764600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.840220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.472600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.87599999978971E-07 |
| Normal-VS-Type2 PRCC |
7.135300E-03 |
| Normal-VS-KIRP CIMP |
5.365000E-01 |
| Normal-VS-Unclassified PRCC |
5.200600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.178400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.693750E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.160900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.490600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.698300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.914400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.057140E-03 |
| Normal-vs-N1 |
7.406400E-01 |
| Normal-vs-N2 |
7.493800E-01 |
| N0-vs-N1 |
7.161600E-02 |
| N0-vs-N2 |
4.185800E-01 |
| N1-vs-N2 |
8.121600E-01 |
|
|
